QC Kinetix is a rapidly growing, highly-rated regenerative medicine company offering cutting-edge, non-surgical solutions for joint pain relief. Established in 2017, the company has expanded its presence to over 100 cities across the country, treating thousands of patients with its innovative therapies.
By utilizing regenerative medicine treatments, QC Kinetix taps into the body’s natural healing potential, enhancing function and offering an alternative to surgical interventions for musculoskeletal issues.
In May 2024, QC Kinetix earned recognition as one of Entrepreneur’s Top 10 New and Emerging Franchises, climbing five spots to rank No. 9. This accolade was based on the company’s exceptional performance in unit growth, financial stability, and brand influence.
Over the past three years, QC Kinetix has experienced a remarkable 2,111% unit growth, securing its place among the industry’s top brands.
“We’re honored to be recognized among the fastest-growing franchises,” said the CEO of QC Kinetix. “This achievement reflects our team’s dedication and hard work. We look forward to further expanding our brand and redefining regenerative medicine.”
Industry Leaders Supporting QC Kinetix
With a strong commitment to patient-centered care, QC Kinetix provides innovative pain relief alternatives without reliance on medications, surgery, or steroids. The company has successfully treated thousands of patients using advanced biologics protocols, reaffirming its commitment to improving quality of life.
Recently, the company appointed Dr. Mitchell Sheinkop, a globally recognized orthopedic surgeon, as its National Medical Director. With over 37 years of expertise in joint replacement surgery, Dr. Sheinkop’s involvement underscores his belief in regenerative medicine’s transformative potential.
In his new role, Dr. Sheinkop will lead the medical management team, refining treatment protocols and driving research and development to keep QC Kinetix at the forefront of medical advancements. His vision includes integrating physical therapy and weight management into current treatment plans to enhance patient outcomes.
His extensive experience, coupled with his commitment to education and professional growth, makes him the ideal leader to steer QC Kinetix into a new era of innovation.
A Brand Backed by Prominent Athletes
The credibility of QC Kinetix extends beyond the medical community, attracting endorsements from renowned athletes like Pro Football Hall of Famer Emmitt Smith, who serves as the company’s national spokesperson.
“I’ve got to keep taking care of these joints,” said Smith. “No losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”
The Story Behind QC Kinetix
The company was founded by a medical doctor, a physician assistant, a nurse practitioner, and a business professional, all united by a vision to revolutionize pain management. They named the company QC Kinetix to honor their Charlotte, North Carolina roots (known as Queen City) and their mission to restore motion and mobility.
Recognizing the limitations of traditional musculoskeletal treatments, QC Kinetix introduced a concierge-style regenerative medicine model, offering safer, more effective alternatives to surgery and medication.
Patients struggling with chronic pain that hinders everyday activities—such as golfing, climbing stairs, or playing with their grandchildren—now have a viable, non-invasive solution that avoids steroids, opioids, and high-risk procedures.
“We didn’t want insurance companies deciding how to treat patients,” said a QC Kinetix spokesperson. “Our goal was to follow research-backed methods, regardless of insurance coverage, and offer transparent, patient-focused care. QC Kinetix aims to be the first choice for pain treatment, not just an alternative.”
A Patient-Centered Approach to Healing
As a leader in regenerative medicine, QC Kinetix empowers patients to maintain an active lifestyle through comprehensive biologic treatments designed to relieve joint and musculoskeletal pain.
By leveraging the body’s natural healing properties, the company provides state-of-the-art, non-invasive therapies, eliminating the need for surgery or addictive painkillers.
Patients seek treatment for conditions affecting the knees, shoulders, and hips, with QC Kinetix offering groundbreaking solutions that utilize the body’s own regenerative capabilities to restore health and function.
Since its inception, the company has achieved significant milestones, including surpassing $100 million in system-wide sales in 2023. In April 2024, the company treated its 40,000th patient since its national expansion in 2021.
“We aim to transform medicine,” the CEO of QC Kinetix stated. “Our goal is for people to think of us first when dealing with pain. The greatest measure of our success is hearing from patients who say our treatments changed their lives. By prioritizing patient care and employee satisfaction, we know growth and success will follow.”
Expanding Into Global Markets
With a solid foundation in the U.S., QC Kinetix is preparing for international expansion into markets such as the United Kingdom, Australia, and New Zealand.
By the end of 2024, the company aims to operate 250 clinics across the United States.
This rapid expansion underscores the rising demand for alternative pain treatments and the growing interest from franchise investors looking to enter the medical sector.
“I love this brand and our future,” said the CEO of QC Kinetix. “It’s all about changing lives and being a true game-changer in the medical field.”